Epigenetic targets in GABAergic neurons to treat schizophrenia.
Costa
E
E
Department of Psychiatry, Psychiatric Institute, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
Dong
E
E
Grayson
D R
DR
Ruzicka
W B
WB
Simonini
M V
MV
Veldic
M
M
Guidotti
A
A
D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D044127:Epigenesis, Genetic / Q000187:drug effects / Q000235:genetics*; D018682:GABA Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D015394:Molecular Structure; D009474:Neurons / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D012559:Schizophrenia / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D014635:Valproic Acid / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D018682:GABA Agents; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid